Overview

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization.
Phase:
Phase 3
Details
Lead Sponsor:
Northwell Health
Collaborators:
AstraZeneca
Jacobi Medical Center
Nassau University Medical Center
Treatments:
Albuterol
Bromides
Budesonide
Ipratropium
Prednisone